Dr Christine Dufès is a Reader (Associate Professor) in Nanomedicine and Director of the Postgraduate School at the Strathclyde Institute of Pharmacy and Biomedical Sciences (SIPBS). She teaches on the Master of Pharmacy and on various MSc postgraduate degrees. Christine obtained a Doctorate in Pharmacy (with Distinction and congratulations of the Jury, 1997) and a PhD (with a European Label, Distinction and congratulations of the Jury, 2002) from the University of Poitiers (France). After four years as a post-doctoral researcher at the Cancer Research UK Beatson Laboratories in Glasgow, she was appointed as a Lecturer at SIPBS in 2006, obtained fellowship of the Higher Education Academy in 2007 and became a Senior Lecturer in 2012 and a Reader in 2019. Her research focuses on the development of targeted drug- and gene-based nanomedicines for cancer therapy and brain delivery. It resulted in 2 patents, 50 peer-reviewed publications in high-impact journals such as Biomaterials and Journal of Controlled Release, 4 book chapters and attracted 3400+ citations (h-index: 27) (Google Scholar). Christine has attracted over £2M in research funding. All her PhD students (from diverse backgrounds) submitted their theses within the imparted time and are now further developing their careers in either Academia or Industry. Christine has been awarded the Bourse d’Excellence Lavoisier (2002), the Award of the 9th Annual Symposium of the United Kingdom and Ireland Controlled Release Society (2003), the Biochemical Journal Young Investigator Award (2009), the Tom Gibson Memorial Award (2012) and the Scientist Medal of the International Association of Advanced Materials (2021) for her research. She also received the “Best Overall” Strathclyde Teaching Excellence Award (2013) for her teaching, was nominated 8 times since 2013 and was shortlisted in the category “Best in Faculty of Science” in 2015 and in 2018. She was the only staff member from her department to be nominated for a Strathclyde Teaching Excellence Award by the students in 2020. She is a Trustee of the British Society of Nanomedicine, Senior Editor of Journal of Interdisciplinary Nanomedicine, Editorial Advisory Board member of Biomaterials Science, Review Editor in Frontiers in Bioengineering and Biotechnology – Nanobiotechnology, and Member of the Editorial Boards of 6 journals (Journal of Liposome Research, Journal of Nanotechnology: Nanomedicine & Nanobiotechnology, Journal of Pharmaceutical Sciences, Pharmaceutical Nanotechnology, Pharmaceutics and Scientia Pharmaceutica).
Mr Jamal Almowalad obtained his Pharm.D degree from King Abdulaziz University (Saudi Arabia, 2009). He then joined Umm Al-Qura University as a teaching assistant at the college of Pharmacy. He moved to the US and received his Master of Science in Pharmaceutical Sciences from the University of Pittsburgh (USA, 2015). He joined the group as a PhD student in 2016 and now works on the development of novel gold nano-hybrids for multimodal cancer therapy.
Miss Jitkasem Meewan obtained her B.Pharm. from Chiang Mai University (Thailand, 2006) and her MSc in Pharmaceutical Technology from Chulalongkorn University (Thailand, 2013). She worked as a pharmacist at Boots (Thailand) and as a Clinical Research Associate at Quintiles (Thailand) where she was a team member in conducting Phase III clinical trials in areas of vaccines, infectious diseases and systemic lupus erythematosus. Jitkasem moved to the UK and received her second MSc in Cancer Sciences from the University of Glasgow in 2016, before joining the group in 2017. She now works on the development of zein nanoparticles for biomedical applications.
Mr Musa Albatsh obtained his Pharm.D degree (2015) and his Master degree in Clinical Pharmacy (2018) from the University of Jordan. During his MSC project, he studied the correlations of Cystatin-C with Pentraxin-3, visceral adiposity index, and atherogenicity index of plasma in metabolic syndrome patients with and without prediabetes. He also worked on a comprehensive survey about blockchain in pharmacy in Jordan. He joined the group as a PhD student in 2019 and now works on tumour microenvironment-sensitive nanomedicine.
Mrs Khadeejah Maeyouf obtained her B.Sc. in Pharmaceutical Sciences from Benghazi University (Libya, 2007). During her graduation project, she studied the anti-inflammatory effect of two new synthetic ketoprofen esters, t-butyl and isopropyl esters. She then worked as a cold circle department manager at Alkufra drug warehouse department (Alkufra, Libya) from January 2011 to March 2013, and was Head of the pharmacy and dispensing pharmacist at Alkufra infectious disease control centre from January 2010 to January 2013. Khadeejah then moved to the UK, joined our group as a MSc student and received her MSc in Advanced Drug Delivery (with distinction) from the University of Strathclyde in 2019. She is now a PhD student and works on nanomedicine-based immunotherapies for cancer treatment.
Miss Hawraa Jerman obtained her Bachelor of Pharmacy (with Distinction) from the University of Sydney (Australia, 2015). She then worked as a hospital pharmacist in Kuwait from 2016 to 2018. In 2018, she joined Kuwait University as a teaching assistant at the Faculty of Pharmacy. Hawraa then moved to the UK, to complete her MSc at the University of Strathclyde, joined our group for her MSc research project and received her MSc in Advanced Drug Delivery (with distinction) in 2019. She is now a PhD student and works on the development of novel tumour-targeted nanomedicines for brain cancer therapy.
Alumni (Postgraduate students)
- Dr Behin Sundara Raj (MPhil, 2008) is now a Lecturer in Pharmaceutics at the Shree Devi College of Pharmacy, Mangalore (India).
- Dr Ju Yen Fu (PhD, 2010) is now a Researcher for the Malaysian Palm Oil Board of the Malaysian Government (Malaysia).
- Dr Hibah Aldawsari (PhD, 2011) is now Associate Professor of Pharmaceutics and Vice-Dean of Faculty of Pharmacy at King Abdulaziz University (Kingdom of Saudi Arabia).
- Dr Reatul Karim (MRes, 2013) is now a Assistant Professor at East West University, Dhaka (Bangladesh).
- Dr Majed Al Robaian (PhD, 2014) is now an Associate Professor and Dean of the School of Pharmacy, Taif University (Kingdom of Saudi Arabia).
- Dr Sukrut Somani (PhD, 2015, PDRA 2015-2019) is now Associate Director CMC Drug Product at BioNTech (Mainz, Germany).
- Mr Stephen Amoah-Nyako (MRes, 2016) is now working as a hospital pharmacist in London
- Ms Paphitchaya Kewcharoenvong (MRes, 2017) is now Associate Project Manager at MedResNet, National Research Council (Mueang Nonthaburi, Nonthaburi, Thailand)
- Dr Najla Altwaijry (PhD, 2018) is now an Assistant Professor and Dean of the College of Pharmacy, Princess Nourah bint Abdulrahman University, Riyadh (Kingdom of Saudi Arabia).
- Dr Joan Erebor (PhD, 2018) is now a Lecturer at the Faculty of Pharmacy, University of Benin (Nigeria) and Visiting Assistant Professor at the College of Pharmacy and Pharmaceutical Sciences at the University of Toledo, Ohio (USA).
- Dr Intouch Sakpakdeejaroen (PhD, 2019) is now an Assistant Professor at the Department of Applied Thai Traditional Medicine, Faculty of Medicine, Thammasat University, Khlong Luang District (Thailand).
- Dr Partha Laskar (PDRA, 2016-2020) is now a Research Associate at the Department of Immunology and Microbiology, Univeristy of Texas Rio Grande Valley (USA).